Additionally, the 36-month beta value for KOD is 2.28. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for KOD is 48.63M and currently, short sellers hold a 4.68% ratio of that float. The average trading volume of KOD on June 13, 2025 was 413.17K shares.
KOD) stock’s latest price update
Kodiak Sciences Inc (NASDAQ: KOD)’s stock price has gone decline by -8.68 in comparison to its previous close of 4.03, however, the company has experienced a -6.12% decrease in its stock price over the last five trading days. prnewswire.com reported 2025-05-29 that PALO ALTO, Calif., May 29, 2025 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that Victor Perlroth, M.D.
KOD’s Market Performance
Kodiak Sciences Inc (KOD) has experienced a -6.12% fall in stock performance for the past week, with a -8.68% drop in the past month, and a 6.67% rise in the past quarter. The volatility ratio for the week is 4.56%, and the volatility levels for the past 30 days are at 7.07% for KOD. The simple moving average for the past 20 days is -1.74% for KOD’s stock, with a -21.48% simple moving average for the past 200 days.
Analysts’ Opinion of KOD
Many brokerage firms have already submitted their reports for KOD stocks, with Jefferies repeating the rating for KOD by listing it as a “Buy.” The predicted price for KOD in the upcoming period, according to Jefferies is $20 based on the research report published on December 09, 2024 of the previous year 2024.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see KOD reach a price target of $3. The rating they have provided for KOD stocks is “Neutral” according to the report published on September 05th, 2024.
Goldman gave a rating of “Sell” to KOD, setting the target price at $2 in the report published on December 11th of the previous year.
KOD Trading at 4.26% from the 50-Day Moving Average
After a stumble in the market that brought KOD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.28% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at KOD starting from BORGESON JOHN A., who sale 2,874 shares at the price of $2.75 back on Jun 17 ’24. After this action, BORGESON JOHN A. now owns 182,164 shares of Kodiak Sciences Inc, valued at $7,904 using the latest closing price.
Stock Fundamentals for KOD
The total capital return value is set at -0.75. Equity return is now at value -108.92, with -52.04 for asset returns.
Based on Kodiak Sciences Inc (KOD), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at -1.58.
Currently, EBITDA for the company is -149.5 million with net debt to EBITDA at 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.62.
Conclusion
In conclusion, Kodiak Sciences Inc (KOD) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
